As patients with axSpA and IBD had no differences in VAS score, BASDAI score, and ASDAS-ESR when compared to those with axSpA without IBD, we can conclude that the higher CRP level, ESR, and serum ET-1 level in patients with axSpA and IBD were due to IBD activity. This evidence concerns the gene EDN1 and inflammatory bowel disease.